Your browser doesn't support javascript.
loading
Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.
Guo, X; Koff, J L; Moffitt, A B; Cinar, M; Ramachandiran, S; Chen, Z; Switchenko, J M; Mosunjac, M; Neill, S G; Mann, K P; Bagirov, M; Du, Y; Natkunam, Y; Khoury, H J; Rossi, M R; Harris, W; Flowers, C R; Lossos, I S; Boise, L H; Dave, S S; Kowalski, J; Bernal-Mizrachi, L.
Afiliación
  • Guo X; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Koff JL; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Moffitt AB; Duke Institute for Genome Sciences and Policy, Department of Medicine, Duke University, Durham, NC, USA.
  • Cinar M; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Ramachandiran S; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Chen Z; Department of Biostatistics and Bioinformatics, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Switchenko JM; Department of Biostatistics and Bioinformatics, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Mosunjac M; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.
  • Neill SG; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.
  • Mann KP; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.
  • Bagirov M; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA.
  • Du Y; Department of Pharmacology, Emory University, Atlanta, GA, USA.
  • Natkunam Y; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
  • Khoury HJ; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Rossi MR; Department of Radiation Oncology, Emory University, Atlanta, GA, USA.
  • Harris W; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Flowers CR; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Lossos IS; Division of Hematology Oncology and Molecular and Cellular Pharmacology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
  • Boise LH; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Dave SS; Duke Institute for Genome Sciences and Policy, Department of Medicine, Duke University, Durham, NC, USA.
  • Kowalski J; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Bernal-Mizrachi L; Department of Biostatistics and Bioinformatics, Winship Cancer Institute of Emory University, Atlanta, GA, USA.
Oncogene ; 36(29): 4224-4232, 2017 07 20.
Article en En | MEDLINE | ID: mdl-28368397
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Subunidad p50 de NF-kappa B / Subunidad p52 de NF-kappa B Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células B Grandes Difuso / Subunidad p50 de NF-kappa B / Subunidad p52 de NF-kappa B Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Oncogene Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos